IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Humana, Inc. (“Humana” or the “Company”) (NYSE: HUM) concerning possible violations of federal securities laws.
If you purchased shares of Humana and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: 949-419-3834, or by e-mail at firstname.lastname@example.org.
According to the Centers for Medicare and Medicaid Services, the percentage of Humana’s membership in four-stars-rated plans or higher fell to roughly 37% in July from 78% the previous year. On October 12, 2016, Humana advised investors that the downgrade of its Medicare star-quality rating could lower its federal reimbursements. The Company stated that it will try “to mitigate any potential negative impact of these published ratings on star bonus revenues for 2018,” including seeking reconsideration of certain ratings, and that the Company believes the decline stems from a recently finished program audit by the Centers for Medicare and Medicaid Services.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: 949-419-3834, or by e-mail at email@example.com.
This press release may constitute Attorney Advertising in some jurisdictions.